Collider bias undermines our understanding of COVID-19 disease risk and severity
- PMID: 33184277
- PMCID: PMC7665028
- DOI: 10.1038/s41467-020-19478-2
Collider bias undermines our understanding of COVID-19 disease risk and severity
Abstract
Numerous observational studies have attempted to identify risk factors for infection with SARS-CoV-2 and COVID-19 disease outcomes. Studies have used datasets sampled from patients admitted to hospital, people tested for active infection, or people who volunteered to participate. Here, we highlight the challenge of interpreting observational evidence from such non-representative samples. Collider bias can induce associations between two or more variables which affect the likelihood of an individual being sampled, distorting associations between these variables in the sample. Analysing UK Biobank data, compared to the wider cohort the participants tested for COVID-19 were highly selected for a range of genetic, behavioural, cardiovascular, demographic, and anthropometric traits. We discuss the mechanisms inducing these problems, and approaches that could help mitigate them. While collider bias should be explored in existing studies, the optimal way to mitigate the problem is to use appropriate sampling strategies at the study design stage.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD013665. doi: 10.1002/14651858.CD013665. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Feb 23;2:CD013665. doi: 10.1002/14651858.CD013665.pub2. PMID: 32633856 Free PMC article. Updated.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Nov 17;11:CD013652. doi: 10.1002/14651858.CD013652.pub2. PMID: 32584464 Free PMC article. Updated.
-
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2020 Aug 26;8(8):CD013705. doi: 10.1002/14651858.CD013705. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705. doi: 10.1002/14651858.CD013705.pub2. PMID: 32845525 Free PMC article. Updated.
-
Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank.BMC Med. 2020 May 29;18(1):160. doi: 10.1186/s12916-020-01640-8. BMC Med. 2020. PMID: 32466757 Free PMC article.
-
Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis.Indian J Med Res. 2020 Jul & Aug;152(1 & 2):105-107. doi: 10.4103/ijmr.IJMR_2251_20. Indian J Med Res. 2020. PMID: 32773417 Free PMC article. No abstract available.
Cited by
-
Tobacco use and risk of COVID-19 infection in the Finnish general population.Sci Rep. 2022 Nov 25;12(1):20335. doi: 10.1038/s41598-022-24148-y. Sci Rep. 2022. PMID: 36434073 Free PMC article.
-
Readmissions for Myocardial Infarction Among Survivors of COVID-19 Hospitalization: Nationwide Analysis From Pandemic Year 2020.JACC Adv. 2023 Jul 27;2(6):100453. doi: 10.1016/j.jacadv.2023.100453. eCollection 2023 Aug. JACC Adv. 2023. PMID: 38939438 Free PMC article.
-
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality.medRxiv [Preprint]. 2021 Mar 12:2021.03.07.21252875. doi: 10.1101/2021.03.07.21252875. medRxiv. 2021. Update in: J Clin Invest. 2021 Dec 1;131(23):e152386. doi: 10.1172/JCI152386. PMID: 33758887 Free PMC article. Updated. Preprint.
-
Reply to Mulla and Pathak: Sleep Apnea and Poor COVID-19 Outcomes: Beware of Causal Intermediates and Colliders.Am J Respir Crit Care Med. 2021 May 15;203(10):1326-1327. doi: 10.1164/rccm.202101-0210LE. Am J Respir Crit Care Med. 2021. PMID: 33684322 Free PMC article. No abstract available.
-
Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.PLoS Med. 2020 Sep 22;17(9):e1003379. doi: 10.1371/journal.pmed.1003379. eCollection 2020 Sep. PLoS Med. 2020. PMID: 32960880 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous